Literature DB >> 24448124

IgG/IgA pemphigus reactive with desmoglein 1 with additional undetermined reactivity with epidermal basement membrane zone.

Amrinder J Kanwar1, Keshavamurthy Vinay, Uma N Saikia, Hiroshi Koga, Kwesi Teye, Daisuke Tsuruta, Takashi Hashimoto.   

Abstract

IgG/IgA pemphigus is an extremely rare subset of pemphigus, showing anti-keratinocyte cell surface antibodies of both IgG and IgA classes. Herein, we describe a unique case of IgG/IgA pemphigus with clinical features of edematous erythema and peripheral vesiculopustules. Histopathology showed the presence of subcorneal pustules and acantholytic blisters in the mid-epidermis with neutrophilic infiltration and eosinophilic spongiosis. Direct immunofluorescence of perilesional skin showed both IgG and IgA deposits to keratinocyte cell surfaces and unusual granular deposits of IgG, IgM, and C3 along basement membrane zone. On enzyme linked immunosorbent assay , the auto-antibodies were found to be reactive to desmoglein 1 antigen. Various clinical, histopathological, and immunological findings in our case overlapped with the features of IgA pemphigus, pemphigus herpetiformis, and pemphigus foliaceus. These findings indicate that IgG/IgA pemphigus may be a transitional form between IgA pemphigus and pemphigus herpetiformis, and thus provides insight into the pathogenicity of this rare disorder.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24448124     DOI: 10.4103/0378-6323.125499

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


  1 in total

1.  Clinical and Immunological Study of 30 Cases With Both IgG and IgA Anti-Keratinocyte Cell Surface Autoantibodies Toward the Definition of Intercellular IgG/IgA Dermatosis.

Authors:  Takashi Hashimoto; Kwesi Teye; Koji Hashimoto; Katarzyna Wozniak; Daisuke Ueo; Sakuhei Fujiwara; Kazuhiro Inafuku; Yorihisa Kotobuki; Ines Lakos Jukic; Branka Marinović; Anna Bruckner; Daisuke Tsuruta; Tamihiro Kawakami; Norito Ishii
Journal:  Front Immunol       Date:  2018-05-07       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.